ETOPOSIDE VIATRIS 20 mg/ml clinical trials

Phase II study to evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendocrine carcinomas - NEONEC D19-01

This study is looking at how well a combination of chemotherapy medicines works before surgery for a specific type of cancer called neuroendocrine carcinoma. It aims to see if this treatment helps people stay cancer-free for longer.